Funding obtained under the CDTI International Technological Cooperation R&D Projects – Multinational Programme for the development of the DALÍ project (PAIS-202441060), focused on the research and validation of an innovative colorectal cancer screening test based on metabolomics technologies using Nuclear Magnetic Resonance (NMR), aimed at its future implementation in clinical practice.
